Home > Insider Trading > Filing (0001127602-14-023899)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231615	Roger Jeffs	C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910	President & Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-07-25	10,000	$30.75	11,234	No	4	M	Direct
Common Stock	Disposition	2014-07-25	9,004	$91.60	2,230	No	4	S	Direct
Common Stock	Disposition	2014-07-25	996	$90.94	1,234	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2014-07-25	10,000	$0.00	10,000	$30.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
80,000		2015-12-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,863	Indirect	By trust
Common Stock	6,773	Indirect	By Jeffs Family LLC

Footnotes

This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $91.12 to $92.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $90.84 to $91.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares held by a family limited liability company of which the reporting person and his spouse are managing members.
These stock options will become exercisable on 12/26/2009.